[96a5a0]: / output / allTrials / identified / NCT01498562_identified.json

Download this file

292 lines (292 with data), 11.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
{
"info": {
"nct_id": "NCT01498562",
"official_title": "Randomized Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Patients With Advanced Non-small Cell Lung Cancer: Dual-agent Molecular Targeting of EGFR (DATE)",
"inclusion_criteria": "* Provision of written informed consent prior to any study specific procedures\n* Unresectable non-small cell lung cancer\n* ECOG performance status of 0 to 2\n* Male or female; ≥ 20 years of age\n* Subjects whose disease has progressed after platinum-based chemotherapy\n* Subjects with measurable lesion\nHealthy volunteers allowed\nMust have minimum age of 20 Years",
"exclusion_criteria": "* Inadequate organ functions\n* Disease progression after 2 or more previous chemotherapy regimens\n* Prior therapy with EGFR-tyrosine kinase inhibitor or Anti-EGFR Monoclonal Ab\n* Any clinically significant gastrointestinal abnormalities\n* Past medical history of interstitial lung disease\n* Pregnant or lactating female",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Provision of written informed consent prior to any study specific procedures",
"criterions": [
{
"exact_snippets": "Provision of written informed consent",
"criterion": "written informed consent",
"requirements": [
{
"requirement_type": "provision",
"expected_value": true
}
]
}
]
},
{
"line": "* Unresectable non-small cell lung cancer",
"criterions": [
{
"exact_snippets": "Unresectable non-small cell lung cancer",
"criterion": "non-small cell lung cancer",
"requirements": [
{
"requirement_type": "resectability",
"expected_value": false
}
]
}
]
},
{
"line": "* ECOG performance status of 0 to 2",
"criterions": [
{
"exact_snippets": "ECOG performance status of 0 to 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Male or female; ≥ 20 years of age",
"criterions": [
{
"exact_snippets": "Male or female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "≥ 20 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Subjects whose disease has progressed after platinum-based chemotherapy",
"criterions": [
{
"exact_snippets": "disease has progressed after platinum-based chemotherapy",
"criterion": "disease progression after platinum-based chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Subjects with measurable lesion",
"criterions": [
{
"exact_snippets": "measurable lesion",
"criterion": "lesion",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 20 Years",
"criterions": [
{
"exact_snippets": "minimum age of 20 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Inadequate organ functions",
"criterions": [
{
"exact_snippets": "Inadequate organ functions",
"criterion": "organ functions",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": false
}
]
}
]
},
{
"line": "* Disease progression after 2 or more previous chemotherapy regimens",
"criterions": [
{
"exact_snippets": "Disease progression",
"criterion": "disease progression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "2 or more previous chemotherapy regimens",
"criterion": "previous chemotherapy regimens",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "regimens"
}
}
]
}
]
},
{
"line": "* Prior therapy with EGFR-tyrosine kinase inhibitor or Anti-EGFR Monoclonal Ab",
"criterions": [
{
"exact_snippets": "Prior therapy with EGFR-tyrosine kinase inhibitor",
"criterion": "EGFR-tyrosine kinase inhibitor therapy",
"requirements": [
{
"requirement_type": "prior therapy",
"expected_value": true
}
]
},
{
"exact_snippets": "Prior therapy with ... Anti-EGFR Monoclonal Ab",
"criterion": "Anti-EGFR Monoclonal Ab therapy",
"requirements": [
{
"requirement_type": "prior therapy",
"expected_value": true
}
]
}
]
},
{
"line": "* Any clinically significant gastrointestinal abnormalities",
"criterions": [
{
"exact_snippets": "clinically significant gastrointestinal abnormalities",
"criterion": "gastrointestinal abnormalities",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* Past medical history of interstitial lung disease",
"criterions": [
{
"exact_snippets": "Past medical history of interstitial lung disease",
"criterion": "interstitial lung disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnant or lactating female",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating female",
"criterion": "lactation status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}